Accelerate Diagnostics, Inc. (AXDX) - Operating Margin

AXDX (Accelerate Diagnostics Inc.) - company brandmark

Accelerate Diagnostics (AXDX) scalability is based on the sale of Pheno systems and high-margin consumables. The target operating margin on GURU.Markets confirms this trend, where the indicator stands at 0.00. Despite the technical expertise of the leadership, management is struggling to achieve profitability. In its expansion phase, Accelerate Diagnostics (AXDX) is implementing rapid sepsis diagnostics, which will become critically important for hospitals by 2026.

acceleratediagnostics.com (AXDX): Operating Profit Rate from 07/04/2022 to 05/24/2025

Financial and market metric breakdowns for Accelerate Diagnostics (AXDX)

Fundamental company analysis:Accelerate Diagnostics, Inc
Brand item of Accelerate Diagnostics Inc

The operating profitability history of Accelerate Diagnostics (AXDX) reflects the efficiency of reagent logistics management and the speed of laboratory supply, directly impacting the business's final margins. This indicator is calculated as the ratio of operating income to revenue, demonstrating the share of net income from core operations before accounting for financial obligations and taxes, which allows investors to assess the internal stability and fundamental reliability of the asset.

Competitor analysis for Accelerate Diagnostics